Novo Nordisk presents phase 3 data for next-generation amylin cagrilintide, leading to advancement into dedicated clinical programme
Conclusion BPC-157 is emerging as one of the most promising gut-healing peptides, with potential benefits spanning ulcers, IBS, gastritis, GERD, and IBD
We don't prescribe trendy protocols without clinical evaluation, we select peptides based on your specific health goals, lab work, and health history
It is more transparent than it used to be, and it is staffed by many people who genuinely believe in the project, but it is still an opaque, self-co-opting body with a 19th-century structure presiding over a 21st-century industry
Untargeted LCMS analysis revealed altered metabolites, such as (ether) phospholipids, acyl carnitines, amino acids, free fatty acids, and bile acids
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41